« Return to News | Awards & Advancement

CEO of the Multiple Myeloma Research Foundation makes the TIME 100 list

Friday, April 22, 2011 12:19 PM

TIME has named Kathy Giusti, Founder and CEO of the Multiple Myeloma Research Foundation (MMRF), to the 2011 TIME 100, the magazine’s annual list of the 100 most influential people in the world.

Guisti was selected for the TIME 100 list for the progress she has made in the way medical research and drug development are conducted and improving the outlook for patients with multiple myeloma, a deadly form of blood cancer, as well as other cancers.

In 2004, Kathy founded the MMRF’s affiliate organization, MMRC to focus on conducting phase I and phase II clinical trials of novel compounds. To date, the MMRC has launched 30 clinical trials of new and combination therapies 60% faster than the industry standard, including eight now in late stage clinical development.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.